Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
L

LH

NYSE

LABCORP HOLDINGS INC.

Latest disclosureSeptember 3, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 11 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 51

Limited filing history
All51Buying0Selling11Other40
Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

40 of 51 trades · March 26, 2026 – September 1, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 40 trades on this page.

Award disclosed

Akinbolade Oyegunwa

EVP, CIO & CTO

Restricted Stock Unit

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 1, 2026Filed September 3, 2026SEC filing
Award disclosed

Jonathan C. Meltzer

EVP, COO

Restricted Stock Unit

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 1, 2026Filed September 3, 2026SEC filing
Award disclosed

Bryan T. Vaughn

EVP and President, Diagnostics

Restricted Stock Unit

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 1, 2026Filed September 3, 2026SEC filing
Award disclosed

Brian J. Caveney

EVP, Pres of BLS, CMO & CSO

Restricted Stock Unit

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 1, 2026Filed September 3, 2026SEC filing
Exercise or conversion

Peter J. Wilkinson

SVP, Chief Accounting Officer

Common Stock

Value context
$279.98K
Reported price
$209.25 / share
Traded August 3, 2026Filed August 5, 2026SEC filing
Exercise or conversion

Peter J. Wilkinson

SVP, Chief Accounting Officer

Non-qualified Stock Options

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$209.25 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 3, 2026Filed August 5, 2026SEC filing
Exercise or conversion

Kathryn W. Kyle

EVP, Chief Legal Officer

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded July 1, 2026Filed July 6, 2026SEC filing
Tax or exercise withholding

Kathryn W. Kyle

EVP, Chief Legal Officer

Common Stock

Value context
$20.72K
Reported price
$283.88 / share
Traded July 1, 2026Filed July 6, 2026SEC filing
Exercise or conversion

Kathryn W. Kyle

EVP, Chief Legal Officer

Restricted Stock Unit

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded July 1, 2026Filed July 6, 2026SEC filing
Exercise or conversion

Bryan T. Vaughn

EVP and President, Diagnostics

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded July 1, 2026Filed July 6, 2026SEC filing
Tax or exercise withholding

Bryan T. Vaughn

EVP and President, Diagnostics

Common Stock

Value context
$26.4K
Reported price
$283.88 / share
Traded July 1, 2026Filed July 6, 2026SEC filing
Exercise or conversion

Bryan T. Vaughn

EVP and President, Diagnostics

Restricted Stock Unit

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded July 1, 2026Filed July 6, 2026SEC filing
Award disclosed

Adam H. Schechter

President & CEO

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 26, 2026Filed March 30, 2026SEC filing
Tax or exercise withholding

Adam H. Schechter

President & CEO

Common Stock

Value context
$7.01M
Reported price
$268.38 / share
Traded March 26, 2026Filed March 30, 2026SEC filing
Award disclosed

Anita Z. Graham

EVP, CHRO

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 26, 2026Filed March 30, 2026SEC filing
Tax or exercise withholding

Anita Z. Graham

EVP, CHRO

Common Stock

Value context
$772.67K
Reported price
$268.38 / share
Traded March 26, 2026Filed March 30, 2026SEC filing
Award disclosed

Mark S. Schroeder

EVP, Pres Diagnostics & COO

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 26, 2026Filed March 30, 2026SEC filing
Tax or exercise withholding

Mark S. Schroeder

EVP, Pres Diagnostics & COO

Common Stock

Value context
$1.23M
Reported price
$268.38 / share
Traded March 26, 2026Filed March 30, 2026SEC filing
Award disclosed

Mark S. Schroeder

EVP, Pres Diagnostics & COO

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 26, 2026Filed March 30, 2026SEC filing
Tax or exercise withholding

Mark S. Schroeder

EVP, Pres Diagnostics & COO

Common Stock

Value context
$393.98K
Reported price
$268.38 / share
Traded March 26, 2026Filed March 30, 2026SEC filing
Award disclosed

Brian J. Caveney

EVP, Pres of ED, CMO & CSO

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 26, 2026Filed March 30, 2026SEC filing
Tax or exercise withholding

Brian J. Caveney

EVP, Pres of ED, CMO & CSO

Common Stock

Value context
$1.08M
Reported price
$268.38 / share
Traded March 26, 2026Filed March 30, 2026SEC filing
Award disclosed

Brian J. Caveney

EVP, Pres of ED, CMO & CSO

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 26, 2026Filed March 30, 2026SEC filing
Tax or exercise withholding

Brian J. Caveney

EVP, Pres of ED, CMO & CSO

Common Stock

Value context
$231.61K
Reported price
$268.38 / share
Traded March 26, 2026Filed March 30, 2026SEC filing
Award disclosed

Peter J. Wilkinson

SVP, Chief Accounting Officer

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 26, 2026Filed March 30, 2026SEC filing
Tax or exercise withholding

Peter J. Wilkinson

SVP, Chief Accounting Officer

Common Stock

Value context
$202.63K
Reported price
$268.38 / share
Traded March 26, 2026Filed March 30, 2026SEC filing
Award disclosed

Bryan T. Vaughn

EVP, Diagnostics

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 26, 2026Filed March 30, 2026SEC filing
Tax or exercise withholding

Bryan T. Vaughn

EVP, Diagnostics

Common Stock

Value context
$121.04K
Reported price
$268.38 / share
Traded March 26, 2026Filed March 30, 2026SEC filing
Award disclosed

der Vaart Sandra D. van

EVP, Corporate Affairs

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 26, 2026Filed March 30, 2026SEC filing
Tax or exercise withholding

der Vaart Sandra D. van

EVP, Corporate Affairs

Common Stock

Value context
$730.53K
Reported price
$268.38 / share
Traded March 26, 2026Filed March 30, 2026SEC filing
Award disclosed

Amy B. Summy

EVP, Chief Marketing Officer

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 26, 2026Filed March 30, 2026SEC filing
Tax or exercise withholding

Amy B. Summy

EVP, Chief Marketing Officer

Common Stock

Value context
$492.75K
Reported price
$268.38 / share
Traded March 26, 2026Filed March 30, 2026SEC filing
Award disclosed

Akinbolade Oyegunwa

EVP, CIO & CTO

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 26, 2026Filed March 30, 2026SEC filing
Tax or exercise withholding

Akinbolade Oyegunwa

EVP, CIO & CTO

Common Stock

Value context
$102.52K
Reported price
$268.38 / share
Traded March 26, 2026Filed March 30, 2026SEC filing
Award disclosed

Jonathan C. Meltzer

EVP, Operations

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 26, 2026Filed March 30, 2026SEC filing
Tax or exercise withholding

Jonathan C. Meltzer

EVP, Operations

Common Stock

Value context
$190.82K
Reported price
$268.38 / share
Traded March 26, 2026Filed March 30, 2026SEC filing
Award disclosed

Kathryn W. Kyle

EVP, Chief Legal Officer

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 26, 2026Filed March 30, 2026SEC filing
Tax or exercise withholding

Kathryn W. Kyle

EVP, Chief Legal Officer

Common Stock

Value context
$121.04K
Reported price
$268.38 / share
Traded March 26, 2026Filed March 30, 2026SEC filing
Award disclosed

Megan D. Bailey

EVP, Pres, Central Labs & Intl

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 26, 2026Filed March 30, 2026SEC filing
Tax or exercise withholding

Megan D. Bailey

EVP, Pres, Central Labs & Intl

Common Stock

Value context
$129.09K
Reported price
$268.38 / share
Traded March 26, 2026Filed March 30, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
EVP, CIO & CTORestricted Stock UnitGrant or awardDerivative units750Award · no purchase priceNon-cash awardSep 1Filed Sep 3 · 2d laterSEC filing
EVP, COORestricted Stock UnitGrant or awardDerivative units900Award · no purchase priceNon-cash awardSep 1Filed Sep 3 · 2d laterSEC filing
EVP and President, DiagnosticsRestricted Stock UnitGrant or awardDerivative units1,500Award · no purchase priceNon-cash awardSep 1Filed Sep 3 · 2d laterSEC filing
EVP, Pres of BLS, CMO & CSORestricted Stock UnitGrant or awardDerivative units3,000Award · no purchase priceNon-cash awardSep 1Filed Sep 3 · 2d laterSEC filing
SVP, Chief Accounting OfficerCommon StockOption exercise or conversion1,338$209.25 / share$279.98KAug 3Filed Aug 5 · 2d laterSEC filing
SVP, Chief Accounting OfficerNon-qualified Stock OptionsOption exercise or conversionDerivative units1,338$209.25 exercise / conversion priceNot a separate purchaseAug 3Filed Aug 5 · 2d laterSEC filing
EVP, Chief Legal OfficerCommon StockOption exercise or conversion10b5-1256Price not reportedUnavailableJul 1Filed Jul 6 · 5d laterSEC filing
EVP, Chief Legal OfficerCommon StockExercise-price or tax withholding10b5-173$283.88 / share$20.72KJul 1Filed Jul 6 · 5d laterSEC filing
EVP, Chief Legal OfficerRestricted Stock UnitOption exercise or conversion10b5-1Derivative units256Exercise / conversion price not reportedNot a separate purchaseJul 1Filed Jul 6 · 5d laterSEC filing
EVP and President, DiagnosticsCommon StockOption exercise or conversion10b5-1327Price not reportedUnavailableJul 1Filed Jul 6 · 5d laterSEC filing
EVP and President, DiagnosticsCommon StockExercise-price or tax withholding10b5-193$283.88 / share$26.4KJul 1Filed Jul 6 · 5d laterSEC filing
EVP and President, DiagnosticsRestricted Stock UnitOption exercise or conversion10b5-1Derivative units327Exercise / conversion price not reportedNot a separate purchaseJul 1Filed Jul 6 · 5d laterSEC filing
President & CEOCommon StockGrant or award58,470Award · no purchase priceNon-cash awardMar 26Filed Mar 30 · 4d laterSEC filing
President & CEOCommon StockExercise-price or tax withholding26,106$268.38 / share$7.01MMar 26Filed Mar 30 · 4d laterSEC filing
EVP, CHROCommon StockGrant or award6,604Award · no purchase priceNon-cash awardMar 26Filed Mar 30 · 4d laterSEC filing
EVP, CHROCommon StockExercise-price or tax withholding2,879$268.38 / share$772.67KMar 26Filed Mar 30 · 4d laterSEC filing
EVP, Pres Diagnostics & COOCommon StockGrant or award9,304Award · no purchase priceNon-cash awardMar 26Filed Mar 30 · 4d laterSEC filing
EVP, Pres Diagnostics & COOCommon StockExercise-price or tax withholding4,600$268.38 / share$1.23MMar 26Filed Mar 30 · 4d laterSEC filing
EVP, Pres Diagnostics & COOCommon StockGrant or award2,968Award · no purchase priceNon-cash awardMar 26Filed Mar 30 · 4d laterSEC filing
EVP, Pres Diagnostics & COOCommon StockExercise-price or tax withholding1,468$268.38 / share$393.98KMar 26Filed Mar 30 · 4d laterSEC filing
EVP, Pres of ED, CMO & CSOCommon StockGrant or award9,304Award · no purchase priceNon-cash awardMar 26Filed Mar 30 · 4d laterSEC filing
EVP, Pres of ED, CMO & CSOCommon StockExercise-price or tax withholding4,042$268.38 / share$1.08MMar 26Filed Mar 30 · 4d laterSEC filing
EVP, Pres of ED, CMO & CSOCommon StockGrant or award1,986Award · no purchase priceNon-cash awardMar 26Filed Mar 30 · 4d laterSEC filing
EVP, Pres of ED, CMO & CSOCommon StockExercise-price or tax withholding863$268.38 / share$231.61KMar 26Filed Mar 30 · 4d laterSEC filing
SVP, Chief Accounting OfficerCommon StockGrant or award10b5-12,388Award · no purchase priceNon-cash awardMar 26Filed Mar 30 · 4d laterSEC filing
SVP, Chief Accounting OfficerCommon StockExercise-price or tax withholding10b5-1755$268.38 / share$202.63KMar 26Filed Mar 30 · 4d laterSEC filing
EVP, DiagnosticsCommon StockGrant or award1,584Award · no purchase priceNon-cash awardMar 26Filed Mar 30 · 4d laterSEC filing
EVP, DiagnosticsCommon StockExercise-price or tax withholding451$268.38 / share$121.04KMar 26Filed Mar 30 · 4d laterSEC filing
EVP, Corporate AffairsCommon StockGrant or award6,382Award · no purchase priceNon-cash awardMar 26Filed Mar 30 · 4d laterSEC filing
EVP, Corporate AffairsCommon StockExercise-price or tax withholding2,722$268.38 / share$730.53KMar 26Filed Mar 30 · 4d laterSEC filing
EVP, Chief Marketing OfficerCommon StockGrant or award3,994Award · no purchase priceNon-cash awardMar 26Filed Mar 30 · 4d laterSEC filing
EVP, Chief Marketing OfficerCommon StockExercise-price or tax withholding1,836$268.38 / share$492.75KMar 26Filed Mar 30 · 4d laterSEC filing
EVP, CIO & CTOCommon StockGrant or award1,340Award · no purchase priceNon-cash awardMar 26Filed Mar 30 · 4d laterSEC filing
EVP, CIO & CTOCommon StockExercise-price or tax withholding382$268.38 / share$102.52KMar 26Filed Mar 30 · 4d laterSEC filing
EVP, OperationsCommon StockGrant or award10b5-12,388Award · no purchase priceNon-cash awardMar 26Filed Mar 30 · 4d laterSEC filing
EVP, OperationsCommon StockExercise-price or tax withholding10b5-1711$268.38 / share$190.82KMar 26Filed Mar 30 · 4d laterSEC filing
EVP, Chief Legal OfficerCommon StockGrant or award1,584Award · no purchase priceNon-cash awardMar 26Filed Mar 30 · 4d laterSEC filing
EVP, Chief Legal OfficerCommon StockExercise-price or tax withholding451$268.38 / share$121.04KMar 26Filed Mar 30 · 4d laterSEC filing
EVP, Pres, Central Labs & IntlCommon StockGrant or award1,184Award · no purchase priceNon-cash awardMar 26Filed Mar 30 · 4d laterSEC filing
EVP, Pres, Central Labs & IntlCommon StockExercise-price or tax withholding481$268.38 / share$129.09KMar 26Filed Mar 30 · 4d laterSEC filing

Congress transactions 11

All Congress filings
Sale disclosed

Labcorp Holdings Inc. Common Stock (LH) · Stock

The filing reports a sale for a dependent.

April McClain Delaney official portraitApril McClain DelaneyReporting House member
Reported amount
$100,001 – $250,000Reported range; exact amount not disclosed.
Trade date
August 25, 2026
Filed September 9, 2026 · 15d laterOriginal report
Partial sale disclosed

Labcorp Holdings Inc. Common Stock (LH) · Stock

The filing reports a partial sale for a dependent.

April McClain Delaney official portraitApril McClain DelaneyReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
August 7, 2026
Filed September 9, 2026 · 33d laterOriginal report
Partial sale disclosed

Labcorp Holdings Inc. Common Stock (LH) · Stock

The filing reports a partial sale for a dependent.

April McClain Delaney official portraitApril McClain DelaneyReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
August 6, 2026
Filed September 9, 2026 · 34d laterOriginal report
Partial sale disclosed

Labcorp Holdings Inc. Common Stock (LH) · Stock

The filing reports a partial sale for a dependent.

April McClain Delaney official portraitApril McClain DelaneyReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
August 5, 2026
Filed September 9, 2026 · 35d laterOriginal report
Purchase disclosed

Labcorp Holdings Inc. Common Stock · Stock

The filing reports a purchase for the member.

AAAlan ArmstrongReporting Senate member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
March 27, 2026
Filed July 21, 2026 · 116d laterOriginal report
Purchase disclosed

Labcorp Holdings Inc. Common Stock (LH) · Stock

The filing reports a purchase for a dependent.

April McClain Delaney official portraitApril McClain DelaneyReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
February 11, 2026
Filed March 10, 2026 · 27d laterOriginal report
Purchase disclosed

Labcorp Holdings Inc. Common Stock (LH) · Stock

The filing reports a purchase for a dependent.

April McClain Delaney official portraitApril McClain DelaneyReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
February 4, 2026
Filed March 10, 2026 · 34d laterOriginal report
Purchase disclosed

Labcorp Holdings Inc. Common Stock (LH) · Stock

The filing reports a purchase for a dependent.

April McClain Delaney official portraitApril McClain DelaneyReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
January 28, 2026
Filed February 2, 2026 · 5d laterOriginal report
Purchase disclosed

Labcorp Holdings Inc. Common Stock (LH) · Stock

The filing reports a purchase for a dependent.

April McClain Delaney official portraitApril McClain DelaneyReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
November 17, 2025
Filed December 8, 2025 · 21d laterOriginal report
Purchase disclosed

Labcorp Holdings Inc. Common Stock (LH) · Stock

The filing reports a purchase for a dependent.

April McClain Delaney official portraitApril McClain DelaneyReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
October 31, 2025
Filed November 4, 2025 · 4d laterOriginal report
Purchase disclosed

Labcorp Holdings Inc. Common Stock (LH) · Stock

The filing reports a purchase for a dependent.

April McClain Delaney official portraitApril McClain DelaneyReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
October 29, 2025
Filed November 4, 2025 · 6d laterOriginal report
Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0000920148
Latest public acceptance
Sep 3, 2026, 12:21 PM UTC
Score calculated
Oct 8, 2026, 12:04 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.